Showing results (291-300 of 390) with videos related to
Sort By:
Pageof 39
The New England Journal of Medicine|July 26, 1990
Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpuraP Samuels, J B Bussel, L E Braitman, et al.Blood|July 24, 2026
BCMA-directed CAR-T cell therapy induces durable drug-free remission in refractory primary immune thrombocytopeniaJinhui Shu, Min Xu, Peiru Li, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 7, 2017
Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight casesHamilton C Tsang, James B Bussel, Susan Mathew, et al.British Journal of Haematology|July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I studyHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.Experimental Brain Research|January 1, 1995
Fictive motor activities in adult chronic spinal rats transplanted with embryonic brainstem neuronsA Yakovleff, J M Cabelguen, D Orsal, et al.Blood|October 19, 2017
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND studyRaymond S M Wong, Mansoor N Saleh, Abderrahim Khelif, et al.Haematologica|August 13, 2016
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopeniaHoward A Liebman, Mansoor N Saleh, James B Bussel, et al.The Journal of Hospital Infection|March 8, 2006
Control of an ACC-1-producing Klebsiella pneumoniae outbreak in a physical medicine and rehabilitation unitS Ohana, P Denys, D Guillemot, et al.American Journal of Obstetrics and Gynecology|May 1, 1996
Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulinJ B Bussel, R L Berkowitz, L Lynch, et al.American Journal of Hematology|February 21, 2019
Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial programJames B Bussel, Donald M Arnold, Michael A Boxer, et al.Pageof 39